BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21483168)

  • 1. Prolonged QRS duration in lead V2 and risk of life-threatening ventricular Arrhythmia in patients with Brugada syndrome.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Nagashima K; Kofune T; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(2):98-102. PubMed ID: 21483168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients.
    Junttila MJ; Brugada P; Hong K; Lizotte E; DE Zutter M; Sarkozy A; Brugada J; Benito B; Perkiomaki JS; Mäkikallio TH; Huikuri HV; Brugada R
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):380-3. PubMed ID: 18081770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan.
    Takagi M; Yokoyama Y; Aonuma K; Aihara N; Hiraoka M;
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1244-51. PubMed ID: 17900255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular conduction delay as marker of risk in Brugada Syndrome. Results from the analysis of clinical and electrocardiographic features of a large cohort of patients.
    Giustetto C; Nangeroni G; Cerrato N; Rudic B; Tülümen E; Gribaudo E; Giachino DF; Barbonaglia L; Biava LM; Carvalho P; Bergamasco L; Borggrefe M; Gaita F
    Int J Cardiol; 2020 Mar; 302():171-177. PubMed ID: 31771792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of fever-induced Brugada syndrome.
    Mizusawa Y; Morita H; Adler A; Havakuk O; Thollet A; Maury P; Wang DW; Hong K; Gandjbakhch E; Sacher F; Hu D; Amin AS; Lahrouchi N; Tan HL; Antzelevitch C; Probst V; Viskin S; Wilde AA
    Heart Rhythm; 2016 Jul; 13(7):1515-20. PubMed ID: 27033637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline fragmented QRS increases the risk of major arrhythmic events in Brugada syndrome: Systematic review and meta-analysis.
    Rattanawong P; Riangwiwat T; Prasitlumkum N; Limpruttidham N; Kanjanahattakij N; Chongsathidkiet P; Vutthikraivit W; Chung EH
    Ann Noninvasive Electrocardiol; 2018 Mar; 23(2):e12507. PubMed ID: 29030919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome.
    Morita H; Miyamoto M; Watanabe A; Tsukuda S; Morimoto Y; Kawada S; Nakagawa K; Nishii N; Ito H
    Heart Rhythm; 2018 Oct; 15(10):1468-1474. PubMed ID: 29953954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and Prognostic Significance of Fragmented QRS in Patients With Brugada Syndrome.
    Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Nakagawa K; Nishii N; Ito H
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogram.
    Delinière A; Baranchuk A; Giai J; Bessiere F; Maucort-Boulch D; Defaye P; Marijon E; Le Vavasseur O; Dobreanu D; Scridon A; Da Costa A; Delacrétaz E; Kouakam C; Eschalier R; Extramiana F; Leenhardt A; Burri H; Winum PF; Taieb J; Bouet J; Fauvernier M; Rosianu H; Carabelli A; Duband B; Chevalier P
    Europace; 2019 Sep; 21(9):1400-1409. PubMed ID: 31177270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome.
    Zumhagen S; Zeidler EM; Stallmeyer B; Ernsting M; Eckardt L; Schulze-Bahr E
    Europace; 2016 Dec; 18(12):1866-1872. PubMed ID: 26941339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan.
    Takagi M; Aonuma K; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M;
    Heart Rhythm; 2013 Apr; 10(4):533-9. PubMed ID: 23274366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
    Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of risk factors of ventricular arrhythmia in patients with Brugada syndrome].
    Shen TT; Geng J; Yuan BB; Chen C; Zhou XJ; Shan QJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):862-867. PubMed ID: 30462974
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk stratification in patients with Brugada syndrome: analysis of daily fluctuations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG).
    Tatsumi H; Takagi M; Nakagawa E; Yamashita H; Yoshiyama M
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):705-11. PubMed ID: 16836663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paced QRS fragmentation is associated with spontaneous ventricular fibrillation in patients with Brugada syndrome.
    Kataoka N; Mizumaki K; Nakatani Y; Sakamoto T; Yamaguchi Y; Tsujino Y; Nishida K; Inoue H
    Heart Rhythm; 2016 Jul; 13(7):1497-503. PubMed ID: 27018377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.